ANXA3 and hepatocellular carcinoma: In fact, returning to the evidence regarding CSCs expressing CD24 and EpCAM and their association with PVT in HCC, researchers including Tong M. et al. have shown that the use of neutralizing monoclonal antibodies against Annexin A3 (ANXA3) effectively eliminated these cells.